- Home
- IMNM vs ERII Comparison
IMNM vs ERII Comparison
Compare IMNM & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- ERII
- Stock Information
- Founded
- IMNM 2006
- ERII 1992
- Country
- IMNM United States
- ERII United States
- Employees
- IMNM N/A
- ERII N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- ERII Industrial Machinery/Components
- Sector
- IMNM Health Care
- ERII Technology
- Exchange
- IMNM Nasdaq
- ERII Nasdaq
- Market Cap
- IMNM 748.3M
- ERII 675.8M
- IPO Year
- IMNM 2020
- ERII 2008
- Fundamental
- Price
- IMNM $8.75
- ERII $12.00
- Analyst Decision
- IMNM Strong Buy
- ERII Strong Buy
- Analyst Count
- IMNM 5
- ERII 4
- Target Price
- IMNM $26.40
- ERII $18.88
- AVG Volume (30 Days)
- IMNM 874.4K
- ERII 424.6K
- Earning Date
- IMNM 08-11-2025
- ERII 07-30-2025
- Dividend Yield
- IMNM N/A
- ERII N/A
- EPS Growth
- IMNM N/A
- ERII 9.93
- EPS
- IMNM N/A
- ERII 0.37
- Revenue
- IMNM $10,938,000.00
- ERII $140,923,000.00
- Revenue This Year
- IMNM N/A
- ERII $4.82
- Revenue Next Year
- IMNM $349.38
- ERII $12.97
- P/E Ratio
- IMNM N/A
- ERII $32.41
- Revenue Growth
- IMNM N/A
- ERII 10.93
- 52 Week Low
- IMNM $5.15
- ERII $10.86
- 52 Week High
- IMNM $16.81
- ERII $20.27
- Technical
- Relative Strength Index (RSI)
- IMNM 48.43
- ERII 39.24
- Support Level
- IMNM $9.02
- ERII $12.10
- Resistance Level
- IMNM $9.91
- ERII $12.65
- Average True Range (ATR)
- IMNM 0.55
- ERII 0.29
- MACD
- IMNM -0.08
- ERII 0.04
- Stochastic Oscillator
- IMNM 9.37
- ERII 17.39
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.